P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 23 August 2019 | 9:04 pm

Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis

INDIANAPOLIS, Aug. 23, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) announced today that baricitinib met the primary more ...

Published 23 August 2019 | 8:39 am

GSK announces positive headline results from the pivotal DREAMM-2 study for multiple myeloma Belantamab mafodotin (GSK2857916) on track for regulatory submission by the end of 2019

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive headline results from the pivotal DREAMM-2 open-label, randomised study of two doses of belantamab more ...

Published 23 August 2019 | 3:04 am

Arbitration panel rules in favor of Lilly in complaint filed by Adocia

INDIANAPOLIS, Aug. 22, 2019 /PRNewswire/ -- A Chicago-based arbitration panel has ruled in favor of Eli Lilly and Company (NYSE: LLY) in a claim filed by Adocia S.A. over the more ...

Published 22 August 2019 | 8:14 pm

Transparency notification BlackRock, Inc.

· Notification referring to situation on 16 August 2019 · Threshold crossed: 5% · Latest holding: 5.19% Brussels (Belgium), 22 August 2019 - 20:00 (CEST) - regulated information more ...

Published 22 August 2019 | 5:38 pm

Investor Update

Tecentriq, an Anti-PD-L1 Antibody, Receives Approval for Additional Indication of Extensive-Stage Small Cell Lung Cancer more ...

Published 22 August 2019 | 8:57 am

FiaspĀ® approved in Europe for the management of diabetes in adolescents and children aged one year and above

Bagsværd, Denmark, 22 August 2019 - Novo Nordisk today announced that the European Commission has granted an extension of the indication for Fiasp ® (fast-acting insulin more ...

Published 22 August 2019 | 8:35 am

Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

China becomes the first country to approve roxadustat for all chronic kidney disease patients with anaemia more ...

Published 22 August 2019 | 8:35 am

AstraZeneca agrees to buy US FDA Priority Review Voucher from Sobi

AstraZeneca today announced that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of $95m from a more ...

Published 22 August 2019 | 8:13 am

ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months

ATLAS-2M study met its primary endpoint, showing similar efficacy of cabotegravir and rilpivirine administered every eight weeks compared to four-week administration. more ...

Published 22 August 2019 | 12:33 am

Device Cybersecurity: #WEHEARTHACKERS

Abbott partners with Cal Poly's California Cybersecurity Institute to challenge hackers and cybersecurity researchers. more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019